Official announcements
Recall
|
Medicines
|
25/05/2018
The marketing authorization holder has informed its supplied customers in a letter dated May 25, 2018, that a blister strip of another product from the same active ingredient group has been discovered in batch W28311 in a single package. As a…
Safety warnings
|
messages in brief
|
23/04/2018
Important information about leaking syringes with some Glaxo SmithKline vacc ines Affected vaccines: Boostrix, Boostrix Polio, Engerix-B, Havrix, Infanrix hexa, Menjugate, Priorix, Priorix-Tetra, Tetanol Pur, Twinrix (adult and pediatric),…
Recall
|
Medicines
|
23/04/2018
The marketing authorization holder has informed its supplied customers in a letter dated April 23, 2018, that a reduced ethanol content was detected during routine release testing. Therefore, the batch 7F307A on the market is recalled as a…
Safety warnings
|
messages in brief
|
20/04/2018
The European Medicines Agency ( EMA) has launched registration for the public consultation. The consultation will take place on 13/06/2018 at the EMA premises. It will be an opportunity for patients, physicians, healthcare professionals, nurses,…
messages in brief
|
17/04/2018
World Hemophilia Day 2018 Hemophilia is a congenital, lifelong increased bleeding tendency in which a deficiency or complete absence of certain blood components (clotting factors) leads to a disturbance of normal hemostasis. Approximately 850,…
Recall
|
Medicines
|
17/04/2018
The marketing authorization holder has informed its supplied customers in a letter dated April 16, 2018, that a shortfall in the protein nitrogen content was detected during an internal quality control and that the affected batch of the Prick Test…
messages in brief
|
12/04/2018
With regard to the APA report "APA0151 5 WI 0205 WB/CI" of Thursday, April 12, 2018, the Federal Office for Safety in Health Care (BASG) takes the liberty of making the following correction: The procedure in question is an official procedure of the…
Recall
|
Medicines
|
23/03/2018
The marketing authorization holder has informed its supplied customers in a letter dated 23.03.2018 that increased anaphylactic reactions have been reported after administration of an identical product in France. For this reason, the above mentioned…
Recall
|
Medicines
|
15/03/2018
The marketing authorization holder has informed its supplied customers in a letter dated March 13, 2018, that cases of immune-mediated encephalitis and meningoencephalitis have been reported in patients treated with Zinbryta. This has resulted in an…
Recall
|
Medicines
|
22/02/2018
The marketing authorization holder has informed its supplied customers in a letter dated 22.02.2018 that it may not be possible to supply all doses. Therefore, the affected batch is recalled from the market as a precautionary measure.